Aequim Alternative Investments’s Teladoc Health TDOC Stock Holding History

Aequim Alternative Investments’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,301	Closed	-$1.67M	–	139
2022 Q2	$1.67M	Sell	50,301 -46,600	-48%	-$1.98M	0.05%	110
2022 Q1	$6.99M	Hold	96,901	–	–	0.18%	80
2021 Q4	$8.9M	Buy	96,901 +901	+0.9%	+$108K	0.28%	66
2021 Q3	$12.2M	Buy	96,000 +33,300	+53%	+$4.85M	0.47%	49
2021 Q2	$10.4M	Sell	62,700 -8,500	-12%	-$1.38M	0.45%	53
2021 Q1	$12.9M	Buy	71,200 +18,400	+35%	+$4.27M	0.84%	31
2020 Q4	$10.6M	Buy	52,800 +42,400	+408%	+$8.62M	0.78%	29
2020 Q3	$2.28M	Buy	+10,400	New	+$2.2M	0.3%	46
2020 Q1	–	Sell	-192,700	Closed	-$16.1M	–	69
2019 Q4	$16.1M	Hold	192,700	–	–	3%	13
2019 Q3	$13.1M	Buy	192,700 +90,900	+89%	+$5.98M	2.61%	13
2019 Q2	$6.76M	Hold	101,800	–	–	1.91%	17
2019 Q1	$5.66M	Buy	101,800 +64,900	+176%	+$3.96M	2.02%	15
2018 Q4	$1.83M	Buy	+36,900	New	+$2.26M	0.93%	21

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Aequim Alternative Investments's TDOC Position: Q3 2022 in Review

Aequim Alternative Investments sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 50,301 shares — an estimated $1.67M sold.

Aequim Alternative Investments first reported a position in TDOC in Q4 2018 and held it in 13 quarters. The position peaked at $16.1M in Q4 2019. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

Aequim Alternative Investments reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
Aequim Alternative Investments sold 50,301 Teladoc Health shares in Q3 2022, an estimated $1.67M.
Aequim Alternative Investments first reported a position in Teladoc Health in Q4 2018 and held it in 13 quarters.
Aequim Alternative Investments's Teladoc Health position peaked at $16.1M in Q4 2019.
483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Aequim Alternative Investments's 13F filing for Q3 2022, filed 14 Nov 2022.